CN Patent

CN117858703A — 用于制备包含利格列汀和盐酸二甲双胍的药物组合物的方法

Assigned to KRKA dd · Expires 2024-04-09 · 2y expired

What this patent protects

本发明涉及用于制备包含利格列汀和盐酸二甲双胍的固体药物组合物的方法，以及可通过该方法获得的固体药物组合物。

USPTO Abstract

本发明涉及用于制备包含利格列汀和盐酸二甲双胍的固体药物组合物的方法，以及可通过该方法获得的固体药物组合物。

Drugs covered by this patent

Patent Metadata

Patent number
CN117858703A
Jurisdiction
CN
Classification
—
Expires
2024-04-09
Drug substance claim
No
Drug product claim
No
Assignee
KRKA dd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.